A Retrospective Study of Clinical Pathways and Outcomes of Andexanet Alfa Administration for Reversal of Critical Bleeding or Urgent Surgery in Patients on Oral Direct Factor Xa Inhibitors

被引：0
|
作者：
Goldin, Mark
Smith, Kolton
Koulas, Ioannis
Leung, Tung Ming
Ravi, Mayuri
Parhar, Sanjit
Shah, Sejal
Floyd, Kayla
Ohanesian, Lori
Bain, Rachel
Defonte, Daniella
Ochani, Kanta
Spyropoulos, Alex
机构：
来源：
CIRCULATION | 2023年 / 148卷
关键词：
Anticoagulation; Thrombosis; Vascular; Progenitor cell;
D O I：
10.1161/circ.148.suppl_1.15557
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A15557
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Clinical Pathways and Outcomes of Andexanet Alfa Administration for the Reversal of Critical Bleeding in Patients on Oral Direct Factor Xa Inhibitors
    Goldin, Mark
    Smith, Kolton
    Koulas, Ioannis
    Leung, Tungming
    Ravi, Mayuri
    Parhar, Sanjit
    Shah, Sejal
    Floyd, Kayla
    Ohanesian, Lori
    Bain, Rachel
    Defonte, Daniella
    Ochani, Kanta
    Lin, Amanda
    Patel, Bhumi
    Tsaftaridis, Nikolaos
    Jnani, Jack
    Spyropoulos, Alex C.
    TH OPEN, 2024, 08 (02) : e209 - e215
  • [2] Utilization and Laboratory Monitoring of Andexanet Alfa Reversal of Factor Xa Inhibitors in Bleeding Patients
    Alipour, Zahra
    Jackups, Ronald
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2020, 154 : S17 - S18
  • [3] Andexanet alfa for reversal of factor Xa inhibitors: a critical review of the evidence
    Abdulrehman, Jameel
    Eikelboom, John W.
    Siegal, Deborah M.
    FUTURE CARDIOLOGY, 2019, 15 (06) : 395 - 404
  • [4] Recommendations for the use of andexanet alfa in the management of bleeding in patients on oral factor Xa inhibitors in Switzerland
    Angelillo-Scherrer, Anne
    Casini, Alessandro
    Studt, Jan-Dirk
    Gerber, Bernhard
    Alberio, Lorenzo A.
    Fontana, Pierre
    SWISS MEDICAL WEEKLY, 2023, 153
  • [5] REVERSAL OF DIRECT FACTOR XA INHIBITORS WITH ANDEXANET ALFA PRIOR TO INVASIVE OR SURGICAL PROCEDURES
    Bradshaw, Paige
    Philpott, Carolyn
    Droege, Christopher
    Droege, Molly
    Ernst, Neil
    Foertsch, Madeline
    Harger, Nicole
    Srinivasan, Vasisht
    Winter, Jessica
    Keegan, Shaun
    CRITICAL CARE MEDICINE, 2022, 50 (01) : 450 - 450
  • [6] Final Study Report of Andexanet Alfa for Major Bleeding With Factor Xa Inhibitors
    Milling, Jr Tuman J.
    Middeldorp, Saskia
    Xu, Lizhen
    Koch, Bruce
    Demchuk, Andrew
    Eikelboom, John W.
    Verhamme, Peter
    Cohen, Alexander T.
    Beyer-Westendorf, Jan
    Gibson, C. Michael
    Lopez-Sendon, Jose
    Crowther, Mark
    Shoamanesh, Ashkan
    Coppens, Michiel
    Schmidt, Jeannot
    Albaladejo, Pierre
    Connolly, Stuart J.
    CIRCULATION, 2023, 147 (13) : 1026 - 1038
  • [7] Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors
    Connolly, S. J.
    Crowther, M.
    Eikelboom, J. W.
    Gibson, C. M.
    Curnutte, J. T.
    Lawrence, J. H.
    Yue, P.
    Bronson, M. D.
    Lu, G.
    Conley, P. B.
    Verhamme, P.
    Schmidt, J.
    Middeldorp, S.
    Cohen, A. T.
    Beyer-Westendorf, J.
    Albaladejo, P.
    Lopez-Sendon, J.
    Demchuk, A. M.
    Pallin, D. J.
    Concha, M.
    Goodman, S.
    Leeds, J.
    Souza, S.
    Siegal, D. M.
    Zotova, E.
    Meeks, B.
    Ahmad, S.
    Nakamya, J.
    Milling, T. J., Jr.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (14): : 1326 - 1335
  • [8] Evaluation of oral factor Xa inhibitor-associated extracranial bleeding reversal with andexanet alfa
    Nederpelt, Charlie J.
    Naar, Leon
    Sylvester, Katelyn W.
    Barra, Megan E.
    Roberts, Russel J.
    Velmahos, George C.
    Kaafarani, Haytham M. A.
    Rosenthal, Martin G.
    King, David R.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2020, 18 (10) : 2532 - 2541
  • [9] Measuring residual anti-Xa activity of direct factor Xa inhibitors after reversal with andexanet alfa
    Bourdin, Matthieu
    Perrotin, Delphine
    Mathieu, Olivier
    Herve, Tristan
    Depasse, Francois
    Lu, Genmin
    Conley, Pamela B.
    Contant, Genevieve
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2021, 43 (04) : 795 - 801
  • [10] Andexanet Alfa for Reversal of Factor Xa Inhibitors in Intracranial Hemorrhage: Observational Cohort Study
    Rauch, Sebastian
    Mueller, Hans-Peter
    Dreyhaupt, Jens
    Ludolph, Albert C.
    Kassubek, Jan
    Althaus, Katharina
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (12)
12345